About SINPHAR GROUP

About SINPHAR GROUP

Life, Health, and Technology

Awards & Certifications

2020

  • SynCore Biotechnology was awarded 2020 Taipei Biotechnology Award-Innovative Technology Award-Excellence Award.
  • Niangjia Lipucan® Capsules developed and produced by Sinphar was awarded the "Nutraceutical Innovation Award" from the Health Food Society of Taiwan.
  • Sinphar Potent Plus Soft Capsules, Its unique anti-fatigue formula was awarded the US invention patent certification (Patent No.: US10485836B2).

2019

  • Sinphar was awarded 2019 Excellent Food Manufacturer Model by the Food and Drug Administration.
  • Sinphar Tianli Pharmaceutical’s newly developed Protygold® Walnut Oligopeptide was the first patented refreshing factor and won the Plant Extract Product Innovation Award of 2019 CPHI China.
  • Sinphar soft Capsules and Powder production line has passed the HALAL certification of MUI.
  • Obtained voluntary GMP certification for good manufacturing of cosmetics.

2018

  • SynCore Biotechnology SB05 (EndoTAG®-1) has been awarded the 15th National Innovation Award in the Startup Company Category by the IBMI.
  • Sinphar Potent Plus Soft Capsules has been approved by the Ministry of Health and Welfare as a nutritional supplements certification for "anti-fatigue function".( DOH Health Food No. A00367)

2017

  • Sinphar Memoregain Capsules has been approved by the Ministry of Health and Welfare as a nutritional supplements certification for " Anti-Aging ".( DOH Health Food No. A00345)
  • Sinphar Migus Phyto-Protein Powder has been approved by the Ministry of Health and Welfare as a nutritional supplements certification for " Regulation of blood lipid".( DOH Health Food No. A00340)
  • Sinphar Steady-Fiber Granulse has been approved by the Ministry of Health and Welfare as a nutritional supplements certification for " Regulation of blood sugar level".( DOH Health Food No. A00327)

2016

  • The Company passed the PIC/S GMP inspection by the Department of Health for its cytotoxic agents (coated tablet) and injections (sterile), providing Taiwan's first production sites that respectively adopt a closed system to manufacture cytotoxic solid agents and an isolator to manufacturer cytotoxic injection agents.
  • Sinphar High Quality Plus Fish Oil Soft Capsules has been approved by the Ministry of Health and Welfare as a nutritional supplements certification for " decrease serum triglycerides".( DOH Health Food No. 000058)
  • SynCore Biotechnology’s SB05/EndoTAG-1, a novel anti-tumor drug receives patent from the European Patent Office for the usage of cationic liposomes embedded with paclitaxel.

2015

  • The Company's Isoacteoside acquired patent from Taiwan.
  • The Company's cytotoxic capsule product passed PIC/S GMP inspection by the Department of Health.
  • SynCore Biotechnology was honored with the Silver Award under Pharmaceutical Group in the 2015 Pharmaceutical Technology Research and Development Award.
  • 子SynCore Biotechnology's SB05 drug acquired patent in Australia and Japan.
  • Sinphar Tianli was recognized as provincial grade high-tech enterprise.
  • He-Tian Tianli was recognized as Xinjiang's new high-tech enterprise and acquired GAP certification from Chinese CFDA, becoming the only GAP-certified base in China for producing Cistanche tubulosa.
  • ZuniMed Biotech passed ISO15378 certification and became the first biotech company in Taiwan to acquire GMP certification from the Ministry of Health and Welfare.

2014

  • Sinphar QH soft gel capsule/ Sinphar Daily Care QH soft gel capsule products received the Health Care Food Innovation Award by the Health Food Society of Taiwan.
  • SynCore Biotechnology acquired TIPS 2014 Verification Certificate from the Information Technology Research Institute (ITRI).
  • SynCore Biotechnology received the New Potential Award in the 2014 Outstanding Biotech Industry Award from the Taiwan Bio Industry Organization.

2013

  • SynCore Biotechnology passed the TIPS inspection by the Industrial Development Bureau, MOEA.
  • SynCore Biotechnology was awarded the 10th National Innovation Award for Enterprise Group/R&D Technology Category.

2012

  • SynCore Biotechnology won the Gold Award in the 2012 Taiwan Biomedical Competition.

2011

  • Passed Taiwan's Department of Health PIC/S GMP inspection and GMP evaluation for plant construction.

2010

  • Product Memoregain received the 2010 Health Care Food Innovation Award.

2009

  • Received the BSI OHSAS18001 certification.
  • After acquiring certification for its function to regulate the immune system, Profulin again acquired the Department of Health's health care food certificate for allergy relief function, making this health care food product a double-certified product that features immune system regulation and allergy relief function.
  • Passed the ISO-22000 food safety certification, adequately demonstrating the Company's stringent control over food safety and quality, which can enhance the Company's international competitiveness.

2008

  • Received the award for the Best Asian Listed Company in the Global Market at an Asia's largest biomedical conference. title title

2007

  • Sinphar Taminace Nutritional Capsule, a six-year R&D outcome exclusive to the Company, can effectively regulate the functions of the immune system and has acquired multinational patents and passed the Department of Health's healthy food certification (DOH-Jian-Shih-Zi-No. A00102).

2005

  • Sinphar Tianli Pharmaceutical (Hangzhou) acquired GMP pharmaceuticals certification.
  • Sinphar Tianli Pharmaceutical (Hangzhou) achieved ISO14001 environment certification.

2004

  • CM1194 testing laboratory has passed TAF ISO17025 international standard certification.
  • CB1193 biolab has passed TAF ISO17025 international standard certification.

2003

  • Passed the ISO9001 quality certification by the Bureau of Standards, Metrology and Inspection.
  • Received the Fourth Industrial Sustainable Excellence Award from the Industrial Development Bureau, MOEA.

2002

  • Won two awards of the National Biotechnology & Medical Care Quality Award from the Institute for Biotechnology and Medicine Industry, specifically (1) Western Medicine Plant group under the Overall Pharmaceutical Plant category, and (2) Self-Developed Western Medicine Product—Phxyol.

2001

  • Passed the first phase cGMP validation and received a gold-engraved award from the Department of Health.

2000

  • CanCap Pharmaceutical acquired Canadian GMP pharmaceutical certification.

1997

  • Passed the ISO9002 quality certification by the Bureau of Standards, Metrology and Inspection.

1996

  • The first domestic pharmaceutical manufacturing industry to win the Fifth SME Award.
TOP